Related Content
Search Google Scholar for:
|
|
Science 20 June 1975: Vol. 188. no. 4194, pp. 1217 - 1219 DOI: 10.1126/science.1145194
|
|
Articles
Science, Vol 188, Issue 4194, 1217-1219
Copyright © 1975 by American Association for the Advancement of Science
Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons
P Seeman
and
T Lee
Neuroleptic (antipsychotic) drugs inhibited the electrically stimulated release of [3-H] dopamine from rat striatal slices. The concentrations for 50 percent inhibition (ranging from 11.5 nanomolar for spiroperidol to 800 nanomolar for thioridazine) correlated closely with the average daily dosages of 25 neuroleptic drugs used clinically for schizophrenia. The correlation includes butyrophenones, phenothiazines, reserpine, pimozide, clozapine, and (plus)- butaclamol. Clinically inactive isomers [trans-thiothixene, trans-flupenthixol, and (minus)-butaclamol] required 20 to 1000 times higher concentrations than the active isomers to inhibit release. Compared to the inhibition of [3-H] dopamine release, much higher neuroleptic concentrations were needed to inhibit the electrically stimulated release of other neurotransmitters--[3-H] acetylcholine, [3-H-a1 (gamma-aminobutyric acid). The neuroleptic drugs may block the presynaptic coupling between impulse and neurosecretion.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Role of dysbindin in dopamine receptor trafficking and cortical GABA function.
- Y. Ji, F. Yang, F. Papaleo, H.-X. Wang, W.-J. Gao, D. R. Weinberger, and B. Lu (2009)
PNAS
106, 19593-19598
| Abstract »
| Full Text »
| PDF »
- Cortical Dopamine D2/D3 Receptors Are a Common Site of Action for Antipsychotic Drugs--An Original Patient Data Meta-analysis of the SPECT and PET In Vivo Receptor Imaging Literature.
- J. M. Stone, J. M. Davis, S. Leucht, and L. S. Pilowsky (2009)
Schizophr Bull
35, 789-797
| Abstract »
| Full Text »
| PDF »
- Presynaptic Regulation of Dopamine Transmission in Schizophrenia.
- G. J. Lyon, A. Abi-Dargham, H. Moore, J. A. Lieberman, J. A. Javitch, and D. Sulzer (2009)
Schizophr Bull
| Abstract »
| Full Text »
| PDF »
- The Effect of Antipsychotics on the High-Affinity State of D2 and D3 Receptors: A Positron Emission Tomography Study With [11C]-(+)-PHNO.
- A. Graff-Guerrero, D. Mamo, C. M. Shammi, R. Mizrahi, H. Marcon, P. Barsoum, P. Rusjan, S. Houle, A. A. Wilson, and S. Kapur (2009)
Arch Gen Psychiatry
66, 606-615
| Abstract »
| Full Text »
| PDF »
- The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway.
- O. D. Howes and S. Kapur (2009)
Schizophr Bull
35, 549-562
| Abstract »
| Full Text »
| PDF »
- Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis.
- O. D. HOWES, A. J. MONTGOMERY, M. ASSELIN, R. M. MURRAY, P. M. GRASBY, and P. K. McGUIRE (2007)
The British Journal of Psychiatry
191, s13-s18
| Abstract »
| Full Text »
| PDF »
- Ether-a-go-go Related Gene Potassium Channels: What's All the Buzz About?.
- P. D. Shepard, C. C. Canavier, and E. S. Levitan (2007)
Schizophr Bull
33, 1263-1269
| Abstract »
| Full Text »
| PDF »
- Involvement of 5-HT1A Receptors in Prefrontal Cortex in the Modulation of Dopaminergic Activity: Role in Atypical Antipsychotic Action.
- L. Diaz-Mataix, M. C. Scorza, A. Bortolozzi, M. Toth, P. Celada, and F. Artigas (2005)
J. Neurosci.
25, 10831-10843
| Abstract »
| Full Text »
| PDF »
- Partial agonism and schizophrenia.
- A. A. Bolonna and R. W. Kerwin (2005)
The British Journal of Psychiatry
186, 7-10
| Full Text »
| PDF »
- D2 receptor regulation of synaptic burst firing in prefrontal cortical pyramidal neurons.
- Y. Wang and P. S. Goldman-Rakic (2004)
PNAS
101, 5093-5098
| Abstract »
| Full Text »
| PDF »
- Delayed-Onset Hypothesis of Antipsychotic Action: A Hypothesis Tested and Rejected.
- O. Agid, S. Kapur, T. Arenovich, and R. B. Zipursky (2003)
Arch Gen Psychiatry
60, 1228-1235
| Abstract »
| Full Text »
| PDF »
- Prefrontal DA Transmission at D1 Receptors and the Pathology of Schizophrenia.
- A. Abi-Dargham and H. Moore (2003)
Neuroscientist
9, 404-416
| Abstract »
| PDF »
- Inverse Agonist Actions of Typical and Atypical Antipsychotic Drugs at the Human 5-Hydroxytryptamine2C Receptor.
- L. Rauser, J. E. Savage, H. Y. Meltzer, and B. L. Roth (2001)
J. Pharmacol. Exp. Ther.
299, 83-89
| Abstract »
| Full Text »
| PDF »
- Neurochemical Individuality: Genetic Diversity Among Human Dopamine and Serotonin Receptors and Transporters.
- A. Cravchik and D. Goldman (2000)
Arch Gen Psychiatry
57, 1105-1114
| Abstract »
| Full Text »
| PDF »
- Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies.
- M. Laruelle and A. Abi-Dargham (1999)
J Psychopharmacol
13, 358-371
| Abstract »
| PDF »
- Selective Action of Acute Systemic Clozapine on Acetylcholine Release in the Rat Prefrontal Cortex by Reference to the Nucleus Accumbens and Striatum.
- M. A. Parada, L. Hernandez, M. P. De Parada, P. Rada, and E. Murzi (1997)
J. Pharmacol. Exp. Ther.
281, 582-588
| Abstract »
| Full Text »
- Analysis of the D4 Dopamine Receptor Gene Variant in an Italian Schizophrenia Kindred.
- F. Macciardi, A. Petronis, H. H. M. Van Tol, C. Marino, M. C. Cavallini, E. Smeraldi, and J. L. Kennedy (1994)
Arch Gen Psychiatry
51, 288-293
| Abstract »
| PDF »
- Burst firing in dopamine neurons induced by N-methyl-D-aspartate: role of electrogenic sodium pump.
- S. Johnson, V Seutin, and R. North (1992)
Science
258, 665-667
| Abstract »
| PDF »
- Early psychopharmacology and the rise of modern brain research.
- A. Carlsson (1990)
J Psychopharmacol
4, 120-126
| PDF »
- Controlled Study of Haloperidol, Pimozide, and Placebo for the Treatment of Gilles de la Tourette's Syndrome.
- E. Shapiro, A. K. Shapiro, G. Fulop, M. Hubbard, J. Mandeli, J. Nordlie, and R. A. Phillips (1989)
Arch Gen Psychiatry
46, 722-730
| Abstract »
| PDF »
- Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients.
- D Pickar, R Labarca, M Linnoila, A Roy, D Hommer, D Everett, and S. Paul (1984)
Science
225, 954-957
| Abstract »
| PDF »
- Pavlovian conditional tolerance to haloperidol catalepsy: evidence of dynamic adaptation in the dopaminergic system.
- C. Poulos and R Hinson (1982)
Science
218, 491-492
| Abstract »
| PDF »
- Schizophrenia: dopamine beta-hydroxylase activity and treatment response.
- D. Sternberg, D. VanKammen, P Lerner, and W. Bunney (1982)
Science
216, 1423-1425
| Abstract »
| PDF »
- Antipsychotic Effects of Pimozide in Schizophrenia: Treatment Response Prediction With Acute Dextroamphetamine Response.
- D. P. van Kammen, J. P. Docherty, S. R. Marder, S. C. Schulz, L. Dalton, and W. E. Bunney Jr (1982)
Arch Gen Psychiatry
39, 261-266
| Abstract »
| PDF »
- Stimulated Lymphocytes in Schizophrenia.
- M. Hirata-Hibi, S. Higashi, T. Tachibana, and N. Watanabe (1982)
Arch Gen Psychiatry
39, 82-87
| Abstract »
| PDF »
- Antipsychotic drug action in schizophrenic patients: effect on cortical dopamine metabolism after long-term treatment.
- N. Bacopoulos, E. Spokes, E. Bird, and R. Roth (1979)
Science
205, 1405-1407
| Abstract »
| PDF »
- Thiethylperazine: Clinical Antipsychotic Efficacy and Correlation With Potency in Predictive Systems.
- J. Rotrosen, B. M. Angrist, S. Gershon, M. Aronson, P. Gruen, E. J. Sachar, R. K. Denning, S. Matthysse, M. Stanley, and S. Wilk (1978)
Arch Gen Psychiatry
35, 1112-1118
| Abstract »
| PDF »
- Neuroleptic-induced "anhedonia" in rats: pimozide blocks reward quality of food.
- R. Wise, J Spindler, H deWit, and G. Gerberg (1978)
Science
201, 262-264
| Abstract »
| PDF »
- Prolactin Responses to Neuroleptics in Normal and Schizophrenic Subjects.
- P. H. Gruen, E. J. Sachar, G. Langer, N. Altman, M. Leifer, A. Frantz, and F. S. Halpern (1978)
Arch Gen Psychiatry
35, 108-116
| Abstract »
| PDF »
- An adenylate cyclase of brain reflects propensity for breast cancer in mice.
- G. Cotzias and L. Tang (1977)
Science
197, 1094-1096
| Abstract »
| PDF »
- Catatonic Reactions to High-Potency Neuroleptic Drugs.
- A. J. Gelenberg and M. R. Mandel (1977)
Arch Gen Psychiatry
34, 947-950
| Abstract »
| PDF »
- Dopamine Receptors and Average Clinical Doses.
- I. CREESE, D. R. BURT, and S. H. SNYDER (1976)
Science
194, 546
| PDF »
- Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs.
- I Creese, D. Burt, and S. Snyder (1976)
Science
192, 481-483
| Abstract »
| PDF »
- The Effect of Neuroleptics on Serum Prolactin in Schizophrenic Patients.
- H. Y. Meltzer and V. S. Fang (1976)
Arch Gen Psychiatry
33, 279-286
| Abstract »
| PDF »
- Self-inhibition by dopaminergic neurons.
- P. Groves, C. Wilson, S. Young, and G. Rebec (1975)
Science
190, 522-528
| PDF »
|
|